Physician profile
William G James
NPI 1851388060
$13,645.88
in general payments reported to CMS, 2019-2025
35 companies · $1,276 in 2025
The $1,276 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,514 · 2020: $1,282 · 2021: $1,058 · 2022: $4,108 · 2023: $3,077 · 2024: $1,331 · 2025: $1,276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,186 · Travel and Lodging: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,186.36 |
| Travel and Lodging | $497.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,437.60 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Mml US, INC. | $1,809.14 | 2022-2023 | Reactiv8 |
| Abbott Laboratories | $1,564.61 | 2019-2025 | Proclaim, Eterna |
| Nevro Corp. | $1,490.56 | 2019-2024 | Senza |
| Boston Scientific Corporation | $756.35 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Pain Management |
| Relievant Medsystems, INC. | $735.24 | 2022-2023 | Intracept |
| Spinal Simplicity, LLC | $587.44 | 2022-2025 | Ha Minuteman G3-R |
| Medtronic USA, INC. | $480.13 | 2019-2020 | |
| Vertiflex, INC. | $429.12 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $383.91 | 2019-2023 | Relistor |
| Vertos Medical, INC. | $357.62 | 2020-2024 | Mild Device Kit |
| Pfizer INC. | $244.89 | 2019-2023 | |
| Tersera Therapeutics LLC | $180.34 | 2019-2023 | Prialt |
| Globus Medical, INC. | $175.80 | 2025 | Senza |
| Nalu Medical, INC. | $172.88 | 2021-2024 | Nalu Neurostimulation System |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $130.51 | 2019-2023 | Ztlido |
| Merz North America, INC. | $103.54 | 2020-2023 | Xeomin |
| Collegium Pharmaceutical, INC. | $102.12 | 2019-2024 | Xtampza |
| Teva Pharmaceuticals USA, INC. | $79.90 | 2020-2023 | Ajovy |
| Merz Pharmaceuticals, LLC | $60.73 | 2024-2025 | Xeomin |
| Vertex Pharmaceuticals Incorporated | $58.20 | 2025 | |
| Stryker Corporation | $31.64 | 2021 | |
| Arbor Pharmaceuticals, INC. | $27.57 | 2021 | |
| Protega Pharmaceutials INC | $27.52 | 2023 | Roxybond |
| Saluda Medical Americas, INC. | $26.88 | 2024 | Evoke |
| Bioventus LLC | $26.07 | 2024 | Durolane |
| Pacira Pharmaceuticals Incorporated | $24.82 | 2023 | Iovera, Zilretta |
| Painteq LLC | $20.88 | 2024 | Painteq |
| Biohaven Pharmaceuticals, INC. | $20.07 | 2021 | |
| Averitas Pharma INC. | $19.81 | 2024 | Qutenza |
| Allergan, INC. | $19.79 | 2020 | |
| Stimwave Technologies Incorporated | $16.44 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.10 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.69 | 2022 | |
| Daiichi Sankyo INC. | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.